IMMEDIATE AND LONG-TERM OUTCOMES OF ROTATIONAL ATHERECTOMY VERSUS BALLOON ANGIOPLASTY ALONE FOR TREATMENT OF DIFFUSE IN-STENT RESTENOSIS

Citation
Sg. Lee et al., IMMEDIATE AND LONG-TERM OUTCOMES OF ROTATIONAL ATHERECTOMY VERSUS BALLOON ANGIOPLASTY ALONE FOR TREATMENT OF DIFFUSE IN-STENT RESTENOSIS, The American journal of cardiology, 82(2), 1998, pp. 140-143
Citations number
13
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
00029149
Volume
82
Issue
2
Year of publication
1998
Pages
140 - 143
Database
ISI
SICI code
0002-9149(1998)82:2<140:IALOOR>2.0.ZU;2-W
Abstract
This study was performed to compare the effects of rotational atherect omy (RA) plus balloon angioplasty (BA) with those of BA alone for trea tment in-stent restenosis. RA+BA or BA alone was performed in a consec utive, prospective (not randomized) manner in 81 patients with 81 diff use in-stent restenotic lesions (lesion length >10 mm): 36 patients un derwent RA+BA, and 45 patients BA. Clinical recurrence was the primary end point of this study, and was defined as angina associated with ob jective evidence of myocardial ischemia on stress testing. Mean follow -up duration was 277 +/- 109 days. In the BA group, acute lumen gain a fter repeat intervention was significantly lower than that of the orig inal stenting procedure (1.94 +/- 0.63 vs 2.37 +/- 0.51 mm, p <0.05). In the RA + BA group, however, acute lumen gain of repeat intervention was similar to that of the original stenting procedure (2.16 +/- 0.52 vs 2.26 +/- 0.66 mm). Clinical recurrence rate at 6 months follow-up was significantly lower in the RA+BA group than in the BA group (25% v s 47%, p <0.05). Clinical events (death, myocardial infarction, repeat intervention) occurred in 6.7% (3 of 45) of patients in the BA group, but in no patient in the RA+BA group during the follow-up period. The long-term angina-free survival rate was significantly higher in the R A+BA group than in the BA group (72% vs 49%, p = 0.02). In conclusion, RA+BA seems to be a more effective therapeutic modality than BA alone for treatment of diffuse in-stent restenosis. (C) 1998 by Excerpta Me dica, Inc.